share_log

Indaptus Therapeutics Announces Results From Second Cohort Of Phase 1 Trial; Initiates Multi-Dose Cohort

Moomoo 24/7 ·  Mar 4 07:33

• Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee to recommend initiating multi-dosing cohort

• Single dose cohort data expected to be published at a scientific conference in 2024

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment